These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18703567)

  • 1. Secretagogues govern GH secretory-burst waveform and mass in healthy eugonadal and short-term hypogonadal men.
    Veldhuis JD; Keenan DM
    Eur J Endocrinol; 2008 Nov; 159(5):547-54. PubMed ID: 18703567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
    Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.
    Norman C; Rollene NL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    Eur J Endocrinol; 2014 Jan; 170(1):121-9. PubMed ID: 24114435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
    Anderson SM; Shah N; Evans WS; Patrie JT; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the size and shape of GH secretory bursts in healthy women using a physiological estradiol clamp and variable-waveform deconvolution model.
    Veldhuis JD; Keenan DM; Bowers CY
    Am J Physiol Regul Integr Comp Physiol; 2007 Sep; 293(3):R1013-21. PubMed ID: 17537842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
    Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.
    Paulo RC; Cosma M; Soares-Welch C; Bailey JN; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Mar; 93(3):944-50. PubMed ID: 18073313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
    Veldhuis JD; Norman C; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4753-60. PubMed ID: 22990092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.
    Veldhuis JD; Keenan DM; Mielke K; Miles JM; Bowers CY
    Eur J Endocrinol; 2005 Oct; 153(4):577-86. PubMed ID: 16189179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
    Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
    Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
    Hudson SB; Schroeder DR; Bailey JN; Mielke KL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2010 Jan; 95(1):353-60. PubMed ID: 19858315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
    Veldhuis JD; Bowers CY
    Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1085-92. PubMed ID: 19240251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential pulsatile secretagogue control of GH secretion in healthy men.
    Norman C; Miles J; Bowers CY; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R712-9. PubMed ID: 23485864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.
    Erickson D; Keenan DM; Farhy L; Mielke K; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1741-51. PubMed ID: 15613434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatized Estrogens Amplify Nocturnal Growth Hormone Secretion in Testosterone-Replaced Older Hypogonadal Men.
    Roelfsema F; Yang RJ; Takahashi PY; Erickson D; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4419-4427. PubMed ID: 30032193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release.
    Friend K; Iranmanesh A; Login IS; Veldhuis JD
    Eur J Endocrinol; 1997 Oct; 137(4):377-86. PubMed ID: 9368506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.